Trends in Medicare Coverage of Overactive Bladder Medications in the United States
Beta-3 agonists had worse coverage across insurers nationwide. Current trends in Medicare coverage reveal a need for improved coverage of preferred OAB medications for an aging population already at risk of cognitive dysfunction.
Authors
- Neha G. Gaddam (ORCID: https://orcid.org/0000-0002-8105-5868)
- Alexis A. Dieter (ORCID: https://orcid.org/0000-0003-0850-3289)
- Megan Wallace
Institutions
- MedStar Washington Hospital Center (US)
- Georgetown University (US)
- MedStar Georgetown University Hospital (US)
Publication Details
- Journal
- Urogynecology
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1097/spv.0000000000001643
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00